VTVT
Price:
$32.765
Market Cap:
$85.75M
vTv Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on creating orally administered treatments, with a significant emphasis on diabetes. Its pipeline features lead candidates such as TTP399, an oral, small-molecule, liver-specific glucokinase activator targeting Type 1 diabetes. Another key investigational drug is HPP737, an oral phosphodiesterase type 4 (PDE4) inhibitor that does not cross the blood-brain barrier (non-CNS penetrant), designed to treat inflammatory conditions and psoriasis. Beyond these, vTv Therapeutics' broader clinical portfolio includes: TTP273, an oral small-molecule GLP-1 receptor agonist addressing postprandial glu...[Read more]
Industry
Biotechnology
IPO Date
2015-07-30
Stock Exchange
NASDAQ
Ticker
VTVT
According to vTv Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.36. This represents a change of 34.63% compared to the average of 10.67 of the last 4 quarters.
The mean historical Current Ratio of vTv Therapeutics Inc. over the last ten years is 3.41. The current 14.36 Current Ratio has changed 42.05% with respect to the historical average. Over the past ten years (40 quarters), VTVT's Current Ratio was at its highest in in the March 2026 quarter at 14.36. The Current Ratio was at its lowest in in the December 2018 quarter at 0.18.
Average
3.41
Median
1.48
Minimum
0.18
Maximum
13.54
Discovering the peaks and valleys of vTv Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 630.89%
Maximum Annual Current Ratio = 13.54
Minimum Annual Increase = -83.41%
Minimum Annual Current Ratio = 0.18
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 13.54 | 84.54% |
| 2024 | 7.34 | 630.89% |
| 2023 | 1.00 | -71.45% |
| 2022 | 3.52 | 91.22% |
| 2021 | 1.84 | 62.80% |
| 2020 | 1.13 | 432.37% |
| 2019 | 0.21 | 15.04% |
| 2018 | 0.18 | -75.62% |
| 2017 | 0.76 | -83.41% |
| 2016 | 4.56 | -60.51% |
The current Current Ratio of vTv Therapeutics Inc. (VTVT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
7.29
5-year avg
5.45
10-year avg
3.41
vTv Therapeutics Inc.’s Current Ratio is greater than MiNK Therapeutics, Inc. (1.38), greater than CervoMed Inc. (6.65), greater than Fortress Biotech, Inc. (2.86), greater than Werewolf Therapeutics, Inc. (1.27), greater than OS Therapies Incorporated (0.05), greater than IO Biotech, Inc. (2.01), greater than Spruce Biosciences, Inc. (4.67), greater than NRx Pharmaceuticals, Inc. (0.29), greater than Outlook Therapeutics, Inc. (0.54), greater than Gain Therapeutics, Inc. (4.69),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.38 | $59.88M | |
| 6.65 | $22.68M | |
| 2.86 | $92.02M | |
| 1.27 | $18.52M | |
| 0.05 | $75.71M | |
| 2.01 | $885.69K | |
| 4.67 | $71.19M | |
| 0.29 | $66.38M | |
| 0.54 | $50.19M | |
| 4.69 | $71.66M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like vTv Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like vTv Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is vTv Therapeutics Inc.'s Current Ratio?
How is the Current Ratio calculated for vTv Therapeutics Inc. (VTVT)?
What is the highest Current Ratio for vTv Therapeutics Inc. (VTVT)?
What is the 3-year average Current Ratio for vTv Therapeutics Inc. (VTVT)?
What is the 5-year average Current Ratio for vTv Therapeutics Inc. (VTVT)?
How does the current Current Ratio for vTv Therapeutics Inc. (VTVT) compare to its historical average?